Mortality and active stents for femoro-popliteal lesions

Abstract

In December 2018, a meta-analysis by Katsanos et al. showed a signal of mortality at two years in patients treated by active balloons and stents compared to bare devices. The authors analyzed in the same group active balloons and active stents. However the technology and the concentrations of paclitaxel differ between these devices. In this study we included the work of Katsanos et al. by individualizing the active stents group.